Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Perioperative Organ Injury in Cardiac Surgery
NCT06118034Phase 3Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jan 2024
- Primary completion
- Aug 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in Atrial fibrillation (AFib), Myocardial injury, acute respiratory distress syndrome (ARDS), postpericardiotomy syndrome (PPS), sponsored by Nanjing Drum-Tower Hospital. Started Jan 2024; status: recruiting.
02
Drugs
colchicine
03
Conditions
Atrial fibrillation (AFib)Myocardial injuryacute respiratory distress syndrome (ARDS)postpericardiotomy syndrome (PPS)
Beyond the preview
Go deeper on NCT06118034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06118034.